

ValiRx Reveals "Clear Impact" Of VAL201 On Prostate Cancer Patients


(Sharecast News) - Clinical stage biotechnology company ValiRx announced on Thursday that the US Patent and Trademark Office has granted patent number...


ValiRx Granted "Key" US Patent Protection For VAL201 Cancer Treatment


ValiRx Raises GBP350,000 Through Placing To Progress Clinical Trials


ValiRx Reports Narrowed Loss In First Half As Expenses Reduce


ValiRx Receives GBP423,000 Research & Development Credit From UK HMRC


(Alliance News) - ValiRx PLC on Tuesday said its VAL201 lead compound is still meeting all of its published endpoints and is behaving as expected in p...


(Alliance News) - Clinical stage biotechnology firm ValiRx PLC said Thursday it has been granted a patent notice of allowance for its pre-clinical the...